🟣 Let's spread the science w/ the power of #SoMe throughout #EuroPCR 2024❗️

Guillaume Bonnet Alessandro Sticchi Alessandro Beneduce Valeria Paradies Chiara De Biase Dejan Milasinovic Salvatore Brugaletta Gabor G Toth DrThomasCuisset nicolas dumonteil Nieves Gonzalo Goran Stankovic, MD, PhD Javier Escaned Tom Johnson Simone Biscaglia Radoslaw Parma

GISE Young’s #CScorner kicked off last week discussing #TAVIchallenges in small annuli!

No worries if you missed it, it’s available at the links below 👇
gise.it/notizie/ordina…
youtube.com/watch?v=zg7P_Y…
Sici GISE Francesco Saia federica serino Marco Toselli

🟣 EAPCI-PCR Fellows Course
#EuroPCR 2024

Hurry up and join your peers to;

🎯Learn
🎯Share
🎯Network

🔗Registiration 👉 bit.ly/3SU7F4C

Gabor G Toth Chiara De Biase Salvatore Brugaletta Dejan Milasinovic Chris Cook Erik Rafflenbeul Valeria Paradies Aaysha Cader Nicola Ryan Stelios Pyxaras

Education to clinical practice and research is key for young interventionalists. Register to this GISE Young initiative.
Sici GISE JIM Congress Arif Khokhar Rossella Ruggiero Journal Club Channel federica serino giulia masiero Marco Toselli Andrea Marrone Jonathan Curio Alessandro Beneduce Giulia Botti

“Exciting”💬“Global”💬”Social”

How would you describe #EuroPCR in one word? 💬

➡️See you in Paris ! 🇫🇷 #CardioTwitter #CardioEd #MedEd #CathLab PCRonline 🫀 European Society of Cardiology #EAPCI

Excited to team up as a roving reporter with Waqas Akhtar for #ISHLT2024 ! As an ICU physician & heart txp recipient, I’ll be sharing the latest in Adv Heart Failure & 🫀🫁 Transplantation from The ISHLT in Prague.

Follow along! 😎🩺

#transplant #medtwitter

💻 Did you miss Episode 1 of #ClinicalCorner ?
🔥Small aortic annulus & hostile vascular access is now available on demand gise.it
👇🏻See below for #TakeHomeMessages

🚨 Episode 2 is coming! #SaveTheDate
🗓️ April 19th, 7:30 AM CEST
🫀Topic: #Imagingchallenges

📢Announcing the #EuroPCR 2024 #SoMe team!

Follow MIЯVΛƬ #IC Belén Cid Alvarez Aaysha Cader A.Nazmi Calik elena Julio Echarte Lynne Hinterbuchner Marta Kaluzna-Oleksy Carlos Luqueño Erik Rafflenbeul Maurizio taramasso Antonin Trimaille to stay up to date with what's 🆕 &🔥in interventional CV medicine!

Transcatheter or Surgical Treatment of Aortic-Valve Stenosis | New England Journal of Medicine nejm.org/doi/full/10.10…
Torsten Doenst Ritu Thamman MD Batman-Echo MA Garcia Fernandez Ovidio García Victoria Delgado Benoy Shah MD Alessandro Beneduce Julia Grapsa Mark J Schuuring Hans-Joachim Schäfers Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦

Original Article: Transcatheter or Surgical Treatment of Aortic-Valve Stenosis (DEDICATE-DZHK6) nej.md/3TLx8MT

Editorial: Another Early Win for TAVI in Low-Risk Patients nej.md/3J5F7j5

American College of Cardiology #ACC24

DanGer Shock Trial
#LBCT #ACC24
⁉️ will use of Impella in pt with STEMI+Shock ⤵️☠️
🫀355 pts, 79% male (where are the women??)
🫀primary endpoint☠️: superior for Impella
🎯 cost: more adverse events: bleed, limb ischemia, renal replacement tx, sepsis
📎 nejm.org/doi/full/10.10…

With Danger Shock RCT we finally have evidence of something we’re believing since several years!

Pts selection and centre’s experience is crucial

The benefit is not only in the in hospital death reduction

Congrats to all the authors

Transcatheter or Surgical Treatment of Aortic-Valve Stenosis | New England Journal of Medicine nejm.org/doi/full/10.10…

Original Article: Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus (SMART) nej.md/49p7VO7

American College of Cardiology #ACC24

After 10 years to complete it, the DanGer-SHOCK trial showed that the routine use of a microaxial flow pump with standard care in the treatment of patients with STEMI-related cardiogenic shock led to a lower risk of death from any cause at 180 days than standard care alone.

The…

🟣 #ACC24 ~ REDUCE-AMI

🫀Beta-blocker vs No beta-blocker in post-MI pts. w/ LVEF ≥ 50%

🚻 5020 / 1:1 randomization / 3.5 y FU

🎯Primary EP ➤ All cause ☠️ or MI

↔️Similar primary outcomes (p=.64)
↔️No diff. in secondary & safety outcomes

Nicola Ryan MIЯVΛƬ #IC

#ACC24 #EMPACT_MI Results discussed with Prof Butler

SGLT2i tested in HFrEF & even pEF so why is this study relevant❓ Because AMI are a special population that are at higher risk

Join us for an in depth discussion

pcronline.com/News/Whats-new…

Shelley Zieroth Dr Ibrahim Bnsadiq Albakri , DRCPSC…

Disruptive results from the SMART trial of #TAVR in small aortic annulus American College of Cardiology #ACC2024 NEJM Didier Tchetche

Presented today at #ACC24 :

In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: nej.md/3xyXU3t

Here we go! Open for discussion now😊